Triomics, a generative AI startup, has raised $15M in Series A funding to automate the process of matching cancer patients with clinical trials. Their software, called OncoLLM, can quickly extract data from electronic health records to find suitable clinical trials for patients. Triomics also has other use cases for their software besides clinical trial matching.
